Published 7 days ago • loading... • Updated 5 days ago
Stronger Weed, Higher Risk? Potent THC Linked to Psychosis and Addiction
Lawmakers are weighing potency limits and warning labels as studies link high-THC products to cannabis use disorder and psychosis in young users.
State legislatures are debating potency caps for legal cannabis products, balancing public health concerns against industry opposition as research links high-potency THC to psychosis.
A systematic review of 99 studies published in the Annals of Internal Medicine in 2025 found strong associations between high-concentration THC products and increased risks for psychosis, schizophrenia, and cannabis use disorder.
Connecticut lawmakers recently reinstated a THC cap on flower, while Washington state Democratic Rep. Lauren Davis has repeatedly proposed safeguards to limit high-potency concentrates, citing safety risks.
The National Cannabis Industry Association argues that blanket caps could push users toward illicit markets, favoring accurate labeling and public education campaigns instead.
Public safety concerns stem from incidents like an Oklahoma case where a young child ingested a 1,000 mg edible, fueling debate over balancing market access with consumer protection.